Opportunity Information: Apply for PAR 13 187

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Reducing the Duration of Untreated Psychosis in the United States (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants.
  • This funding opportunity was created on Apr 10, 2013 and posted on Apr 10, 2013.
  • Applicants must submit their applications by May 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
  • Eligible applicants include: County governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal governments (Federally recognized) Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Independent school districts Public housing authorities/Indian housing authorities City or township governments For profit organizations other than small businesses State governments Small businesses.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Apply for PAR 13 187

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH funding opportunity PAR 13-187, titled "Reducing the Duration of Untreated Psychosis in the United States (R01)," is a discretionary research grant program designed to support studies that meaningfully shorten the time between the onset of psychotic symptoms and entry into appropriate specialty care for first episode psychosis (FEP). The central public health problem driving the announcement is the large number of adolescents and young adults who develop psychosis each year in the U.S. (estimated around 100,000 annually) and the persistent, well-documented delay in getting effective treatment. Even though coordinated, multi-element FEP specialty care programs have been shown to improve both clinical symptoms and real-world functioning, many individuals do not reach these services quickly. The FOA emphasizes that the early phase of psychotic illness is a critical window for prevention of deterioration and for altering long-term trajectories associated with serious mental illnesses such as schizophrenia.

A core concept in this announcement is the duration of untreated psychosis (DUP), which refers to the length of time between the onset of psychotic symptoms and the start of adequate treatment. The FOA highlights that in the United States DUP is commonly delayed by one to three years, which is far longer than what is considered clinically desirable. Since better outcomes are consistently linked to earlier engagement in treatment, the announcement frames long DUP as a major, addressable systems problem rather than an unavoidable feature of illness. It points to the World Health Organization benchmark advocating for DUP of three months or less, and it calls for practical approaches to move the U.S. closer to that target.

The purpose of the R01s supported under this FOA is to test reproducible strategies that substantially reduce DUP by removing major bottlenecks along the pathway to specialty FEP care. In practical terms, this means funding research that identifies where people get stuck or drop out between first symptom onset and specialty treatment, then evaluates interventions that streamline early identification, speed referrals, and improve engagement in phase-specific care. The announcement is oriented toward real-world implementation challenges, such as delays in recognizing early psychosis, fragmented referral routes, limited awareness among first-contact settings, and barriers that prevent young people and families from connecting to specialized services quickly. The emphasis on "reproducible" strategies signals interest in approaches that are clearly defined, can be reliably implemented in multiple settings, and have the potential to be scaled or adopted beyond a single local context.

In terms of administrative details, this is an NIH R01 grant mechanism within the health research category, associated with CFDA 93.242 (Mental Health Research Grants). The FOA had set-aside funds, with an estimated total funding level of $2,000,000 across the initiative, and it did not require cost sharing or matching. The opportunity was posted and created on April 10, 2013, with an original and final closing date of May 7, 2016, and it was archived on June 7, 2016. While the archived status means the specific solicitation window has closed, the summary still reflects the goals and priorities NIH sought to advance through this particular call for research.

Eligibility under the FOA was broad and included many types of domestic organizations and governments, reflecting the program's focus on system-level pathways to care that can involve healthcare providers, schools, community agencies, and public systems. Eligible applicants included state, county, city or township governments, special district governments, independent school districts, public housing authorities/Indian housing authorities, tribal governments and tribal organizations, and regional organizations. It also included public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories), small businesses, and for-profit organizations other than small businesses. The FOA also explicitly listed categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and Asian American and Native American Pacific Islander-serving institutions (AANAPISIs), as well as faith-based and community-based organizations and eligible federal agencies. Non-U.S. entities were not eligible to apply, and non-U.S. components of U.S. organizations were not eligible, although foreign components (as NIH defines them) were allowed, indicating that limited international collaboration could be included when justified within a U.S.-focused project.

Overall, the grant opportunity is best understood as an NIH effort to push the field beyond documenting long treatment delays and toward testing concrete, scalable solutions that reduce those delays. The program ties the clinical importance of early psychosis intervention to a systems engineering style problem: finding and fixing the points in the identification-to-treatment pipeline that create months or years of unnecessary waiting. The intended endpoint is not simply more awareness of early psychosis, but demonstrably faster access to specialty FEP care and improved engagement at the exact stage when intervention is most likely to prevent functional decline.

FAQs: NIH PAR 13-187 - Reducing the Duration of Untreated Psychosis in the United States (R01)

What is PAR 13-187?

PAR 13-187 is an NIH funding opportunity announcement (FOA) titled "Reducing the Duration of Untreated Psychosis in the United States (R01)." It supported discretionary research grants using the NIH R01 mechanism to test strategies that meaningfully shorten the time between the onset of psychotic symptoms and entry into appropriate specialty care for first episode psychosis (FEP).

What problem was this FOA trying to address?

The FOA focused on the persistent delay many adolescents and young adults face in getting effective treatment after psychotic symptoms begin. It noted that an estimated 100,000 adolescents and young adults develop psychosis each year in the United States, and that delays in reaching appropriate specialty care remain common and well documented.

What does "duration of untreated psychosis (DUP)" mean?

DUP refers to the length of time between the onset of psychotic symptoms and the start of adequate treatment. The FOA treated DUP as a key measure because shorter DUP is consistently linked to better outcomes.

How long is DUP typically delayed in the United States, according to the FOA?

The FOA stated that in the United States, DUP is commonly delayed by one to three years, which is much longer than what is clinically desirable.

What DUP benchmark did the FOA reference?

The FOA cited a World Health Organization benchmark advocating for a DUP of three months or less, and it called for practical approaches to move the United States closer to that target.

Why is reducing DUP considered important?

The FOA emphasized that the early phase of psychotic illness is a critical window for prevention of deterioration and for altering long-term illness trajectories associated with serious mental illnesses such as schizophrenia. It also highlighted that earlier engagement in treatment is consistently associated with better clinical and real-world functioning outcomes.

What type of care was the FOA trying to help people reach sooner?

The FOA aimed to speed entry into coordinated, multi-element specialty care programs designed for first episode psychosis (FEP). It noted that these programs have been shown to improve both clinical symptoms and real-world functioning.

What kinds of projects were encouraged under this R01?

The FOA encouraged studies that identify bottlenecks along the pathway from first symptom onset to specialty FEP treatment and then test interventions to remove those bottlenecks. Examples of the targeted pathway issues included delays in recognizing early psychosis, fragmented referral routes, limited awareness in first-contact settings, and barriers that prevent young people and families from connecting quickly to specialized services.

What does the FOA mean by "reproducible strategies" to reduce DUP?

In this FOA, "reproducible" strategies referred to approaches that are clearly defined, can be reliably implemented across multiple settings, and have the potential to be scaled or adopted beyond a single local context.

Was this FOA focused more on documenting delays or on testing solutions?

It was explicitly oriented toward testing concrete solutions. The FOA framed long DUP as a major, addressable systems problem and sought research that goes beyond describing delays to evaluating interventions that streamline identification, referral, and engagement in phase-specific specialty care.

What grant mechanism did NIH use for this opportunity?

This opportunity used the NIH R01 research project grant mechanism.

What is the CFDA number associated with this FOA?

The FOA was associated with CFDA 93.242 (Mental Health Research Grants).

How much funding was available under this initiative?

The FOA indicated set-aside funds with an estimated total funding level of $2,000,000 across the initiative.

Was cost sharing or matching required?

No. The FOA stated that cost sharing or matching was not required.

When was this funding opportunity posted, and when did it close?

The FOA was posted and created on April 10, 2013. It listed an original and final closing date of May 7, 2016.

Is PAR 13-187 still open for applications?

No. The FOA is archived. It was archived on June 7, 2016, and the solicitation window described in the announcement has closed.

Who was eligible to apply?

Eligibility was broad and included many types of domestic organizations and governments. Eligible applicants included state, county, city or township governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; tribal governments and tribal organizations; and regional organizations. It also included public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories), small businesses, and for-profit organizations other than small businesses.

Did the FOA include institution types such as HBCUs or Hispanic-serving institutions?

Yes. The FOA explicitly listed categories including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and Asian American and Native American Pacific Islander-serving institutions (AANAPISIs). It also included faith-based and community-based organizations and eligible federal agencies.

Were non-U.S. entities eligible to apply?

No. The FOA stated that non-U.S. entities were not eligible to apply, and non-U.S. components of U.S. organizations were not eligible.

Were any international activities allowed at all?

Yes, in a limited way. The FOA allowed foreign components (as NIH defines them), meaning international collaboration could be included when justified within a U.S.-focused project.

What settings or systems did the FOA imply might be involved in reducing DUP?

The FOA framed DUP as a system-level pathway to care problem and noted that relevant pathways can involve healthcare providers, schools, community agencies, and public systems, especially where first contact and referrals occur.

What outcomes was the FOA ultimately trying to improve?

The intended endpoint was faster access to specialty FEP care and improved engagement during the early phase of illness, when intervention is most likely to prevent deterioration and functional decline.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Reducing the Duration of Untreated Psychosis in the United States (R34)

Previous opportunity: Viral Hepatitis Networking, Capacity Building and Training

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 13 187

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 13 187) also looked into and applied for these:

Funding Opportunity
Reducing the Duration of Untreated Psychosis in the United States (R34) Apply for PAR 13 188

Funding Number: PAR 13 188
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Methods Development in Natural Products Chemistry (SBIR)(R43) Apply for RFA AT 14 001

Funding Number: RFA AT 14 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Methods Development in Natural Products Chemistry (STTR) (R41) Apply for RFA AT 14 002

Funding Number: RFA AT 14 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
FY13 Announcement of Anticipated Availability of Funds for the Adoption and Implementation of Health Information Technology in Family Planning Services Grants Region 2 Apply for PA FPH 13 043

Funding Number: PA FPH 13 043
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $250,000
FY13 Announcement of Anticipated Availability of Funds for the Adoption and Implementation of Health Information Technology in Family Planning Services Grants Region 1 Apply for PA FPH 13 042

Funding Number: PA FPH 13 042
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $250,000
FY13 Announcement of Anticipated Availability of Funds for the Adoption and Implementation of Health Information Technology in Family Planning Services Grants Region 3 Apply for PA FPH 13 044

Funding Number: PA FPH 13 044
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $250,000
FY13 Announcement of Anticipated Availability of Funds for the Adoption and Implementation of Health Information Technology in Family Planning Services Grants Region 4 Apply for PA FPH 13 045

Funding Number: PA FPH 13 045
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $250,000
FY13 Announcement of Anticipated Availability of Funds for the Adoption and Implementation of Health Information Technology in Family Planning Services Grants Region 9 Apply for PA FPH 13 050

Funding Number: PA FPH 13 050
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $250,000
FY13 Announcement of Anticipated Availability of Funds for the Adoption and Implementation of Health Information Technology in Family Planning Services Grants Region 6 Apply for PA FPH 13 047

Funding Number: PA FPH 13 047
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $250,000
FY13 Announcement of Anticipated Availability of Funds for the Adoption and Implementation of Health Information Technology in Family Planning Services Grants Region 5 Apply for PA FPH 13 046

Funding Number: PA FPH 13 046
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $250,000
FY13 Announcement of Anticipated Availability of Funds for the Adoption and Implementation of Health Information Technology in Family Planning Services Grants Region 7 Apply for PA FPH 13 048

Funding Number: PA FPH 13 048
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $250,000
FY13 Announcement of Anticipated Availability of Funds for the Adoption and Implementation of Health Information Technology in Family Planning Services Grants Region 8 Apply for PA FPH 13 049

Funding Number: PA FPH 13 049
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $250,000
FY13 Announcement of Anticipated Availability of Funds for the Adoption and Implementation of Health Information Technology in Family Planning Services Grants Region 10 Apply for PA FPH 13 051

Funding Number: PA FPH 13 051
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $250,000
National Network to Enhance Capacity of State and Local Sexually Transmitted Disease Prevention Programs (NNECS) Apply for CDC RFA PS13 1309

Funding Number: CDC RFA PS13 1309
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $950,000
Integration of Care and Support within the Health System to Support Better Patient Outcomes Apply for RFA 674 13 000003

Funding Number: RFA 674 13 000003
Agency: South Africa USAID Pretoria
Category: Health
Funding Amount: $25,000,000
Structural Interventions, Alcohol Use, and Risk of HIV/AIDS (R01) Apply for PA 13 191

Funding Number: PA 13 191
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Structural Interventions, Alcohol Use, and Risk of HIV/AIDS (R21) Apply for PA 13 192

Funding Number: PA 13 192
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
State Oral Disease Prevention Program Apply for CDC RFA DP13 1307

Funding Number: CDC RFA DP13 1307
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $250,000
Mechanisms of Alcohol and Nicotine Co Addiction (R21) Apply for PA 13 193

Funding Number: PA 13 193
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Mechanisms of Alcohol and Nicotine Co Addiction (R01) Apply for PA 13 194

Funding Number: PA 13 194
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 187", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.